source
- U.S. drug shortages climb to 227 active cases in Q2 2026The United States reported a rise in active medication shortages during the second quarter of 2026, with the total reaching 227. The increase signals growing pressure on the pharmaceutical supply…
- GSK drops chronic cough drug camlipixant after mixed Phase 3 resultsGSK announced it will stop investing in camlipixant for refractory chronic cough after the drug failed to meet key endpoints in a late-stage trial. The company had run two Phase 3 studies, CALM-1…